Beacon Therapeutics is Seeking Participants with X-linked Retinitis Pigmentosa
Beacon Therapeutics is Seeking Participants with X-linked Retinitis Pigmentosa Who Have a Mutation (or Defect) in the RPGR Gene for Their Multi-Center, Phase 2/3 Vista Trial To be considered for…